Aprecia Pharmaceuticals raised $14.9 million in a debt financing, according to documents filed with the Securities and Exchange Commission.
The Langhorne, Pa., company is seeking to raise a total of $36.2 million through the debt sale.
Aprecia’s focus is on developing precision drug-delivery systems and products.
Its ZipDose delivery system, in development for the past decade, provides for the rapid dispersion of a variety of therapeutic products. Read more about this story on PBJ.com
More NBC10.com stories:
